NCT05869487 Calf Circumference Versus X-ray Absorptiometry in the Diagnosis of Sarcopenia in Elderly Hospitalized Patients
| NCT ID | NCT05869487 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Régional d'Orléans |
| Condition | Sarcopenia |
| Study Type | INTERVENTIONAL |
| Enrollment | 298 participants |
| Start Date | 2023-12-11 |
| Primary Completion | 2027-04-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 298 participants in total. It began in 2023-12-11 with a primary completion date of 2027-04-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective single-center study to evaluate a diagnostic method. The main objective of the study is to evaluate the performance of calf circumference as a diagnostic method for sarcopenia in hospitalized elderly people, compared to a gold standard method which is X-ray absorptiometry. The study population are hospitalizing participants aged 75 years and older with an indication to search for sarcopenia.
Eligibility Criteria
Inclusion Criteria: * Age greater than or equal to 75 years * Hospitalization in a medical department or in the follow-up care or rehabilitation department of the Hospital Center of Orléans * Presence of an etiological criterion of undernutrition * Presence of a decrease in muscle strength Exclusion Criteria: * Presence of one of two phenotypic criteria for undernutrition other than sarcopenia, which are body mass index less than 22 kilogram per square meter and weight loss (≥ 5 percent over 1 month or ≥ 10 percent over 6 months or ≥10 percent compared with usual weight before the disease). * Refusal to participate in the study * Patient under legal protection * Impossible to perform X-ray absorptiometry (behavioral problems, functional constraints to climb on the DXA machine) * Person not affiliated to a social security system
Contact & Investigator
Matthieu COULONGEAT, MD
PRINCIPAL INVESTIGATOR
CHR d'Orléans
Frequently Asked Questions
Who can join the NCT05869487 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05869487 currently recruiting?
Yes, NCT05869487 is actively recruiting participants. Contact the research team at elodie.pougoue-touko@chr-orleans.fr for enrollment information.
Where is the NCT05869487 trial being conducted?
This trial is being conducted at Orléans, France.
Who is sponsoring the NCT05869487 clinical trial?
NCT05869487 is sponsored by Centre Hospitalier Régional d'Orléans. The principal investigator is Matthieu COULONGEAT, MD at CHR d'Orléans. The trial plans to enroll 298 participants.